Medicine:72F fusion protein vaccine

From HandWiki
Revision as of 18:26, 25 May 2021 by imported>John Marlo (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

72F fusion protein vaccine is a candidate tuberculosis vaccine created by Statens Serum Institut (SSI). The 72F fusion protein is composed of the Rv0125 and Rv1196 proteins derived from Mycobacterium tuberculosis. Phase I clinical trials were completed in 2005 and Phase II trials are awaited.

See also

  • Fusion protein

References